| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Royalty Pharma plc
13D/A
Amendment 1
RPRX · G7709Q104
|
18.7% |
8/17/2026
Event 8/13/2026
|
|||
| Legorreta G. Pablo | 18.7% | ||||
| Legorreta Investments, LLC | 7.8% | ||||
|
Royalty Pharma plc
13D
RPRX · G7709Q104
|
19.7% |
5/23/2025
Event 5/16/2025
|
|||
| Legorreta G. Pablo | 19.7% | ||||
| Legorreta Investments, LLC | 8.1% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.